Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Jamerson

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|January 31, 2003
Therapeutic lifestyle changes for hypertension and cardiovascular risk reductionKarol Watson, Kenneth Jamerson
Current Hypertension Reports|January 30, 2014
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertensionJames Brian Byrd, George Bakris, Kenneth Jamerson
Blood Pressure|July 8, 2020
Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-StudyMagnus Holanger, Sverre E Kjeldsen, Kenneth Jamerson, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) studyLuis M Ruilope, Antonio Salvetti, Kenneth Jamerson, et al.
Journal of the American Heart Association|July 26, 2024
Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular OutcomesElaine Ku, Kenneth Jamerson, Timothy P Copeland, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2010
Avosentan for overt diabetic nephropathyJohannes F E Mann, Damian Green, Kenneth Jamerson, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2018
Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of DeathElaine Ku, Joachim H Ix, Kenneth Jamerson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2002
Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension TrialJohn W Kusek, Paul Greene, Shin-Ru Wang, et al.
Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.
International Journal of Nephrology|October 9, 2013
Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosisOtelio Randall, John Kwagyan, Tamrat Retta, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Hypertension (Greenwich, Conn.)|January 31, 2003
Therapeutic lifestyle changes for hypertension and cardiovascular risk reductionKarol Watson, Kenneth Jamerson
Current Hypertension Reports|January 30, 2014
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertensionJames Brian Byrd, George Bakris, Kenneth Jamerson
Blood Pressure|July 8, 2020
Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-StudyMagnus Holanger, Sverre E Kjeldsen, Kenneth Jamerson, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) studyLuis M Ruilope, Antonio Salvetti, Kenneth Jamerson, et al.
Journal of the American Heart Association|July 26, 2024
Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular OutcomesElaine Ku, Kenneth Jamerson, Timothy P Copeland, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2010
Avosentan for overt diabetic nephropathyJohannes F E Mann, Damian Green, Kenneth Jamerson, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2018
Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of DeathElaine Ku, Joachim H Ix, Kenneth Jamerson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 6, 2002
Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension TrialJohn W Kusek, Paul Greene, Shin-Ru Wang, et al.
Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.
International Journal of Nephrology|October 9, 2013
Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosisOtelio Randall, John Kwagyan, Tamrat Retta, et al.
Pageof 5